Clifford J. Rosen
Maine Medical Center
717 Papers
6.3K Citations
Clifford J. Rosen is an academic researcher from Maine Medical Center. The author has contributed to research in topics: Osteoporosis & Bone density. The author has an hindex of 111, co-authored 655 publications. Previous affiliations of Clifford J. Rosen include Veterans Health Administration & Thomas Jefferson University.
Chat about Author
Papers
Changes in marrow adipose tissue with short-term changes in weight in premenopausal women with anorexia nervosa.
Pouneh K. Fazeli,Alexander T. Faje,Miriam A. Bredella,Sai P. Polineni,Stephen J Russell,Megi Resulaj,Clifford J. Rosen,Anne Klibanski +7 more
TL;DR: In this paper, the authors conducted a 12-month longitudinal study including 46 premenopausal women (n = 26 with anorexia nervosa and n = 20 normal-weight controls) with a mean (s.e.m.) age of 28.2 ± 0.8 years.
•Journal Article
Sex steroids, the insulin-like growth factor regulatory system, and aging: implications for the management of older postmenopausal women.
TL;DR: The role of IGF-I (and its constituent IGF binding proteins) in skeletal and vascular tissue is defined and it is likely that the IGF regulatory system will be a prime target for future studies into the pathogenesis of several age and sex hormone related degenerative disorders.
21
Traveling down the Long Road to Type 1 Diabetes Mellitus Prevention.
TL;DR: A person diagnosed with type 1 diabetes mellitus is likely to have a higher risk of developing type 2 diabetes, which is a chronic autoimmune disease that usually begins in childhood, and the likelihood of developing Type 2 diabetes is higher.
21
Cthrc1 controls adipose tissue formation, body composition, and physical activity
J. Patrizia Stohn,Qiaozeng Wang,Matthew E. Siviski,Kevin Kennedy,Yong-Ri Jin,Doreen Kacer,Victoria E. DeMambro,Lucy Liaw,Calvin P.H. Vary,Clifford J. Rosen,Igor Prudovsky,Volkhard Lindner +11 more
TL;DR: This study investigated the effects of loss of Cthrc1 on adipogenesis, body composition, metabolism, Physical activity, physical activity, and muscle physiology.
21
Finerenone - Halting Relative Hyperaldosteronism in Chronic Kidney Disease.
TL;DR: Type 2 diabetes is the most common cause of chronic kidney disease (CKD) and end-stage renal disease and the risk of progression of kidney disease is very high among patients with diabetes.
21